PubRank

M J Buxton

Author PubWeight™ 67.12‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 2002 10.52
2 Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess 1998 9.32
3 Cost-benefit analysis of long-term haemodialysis for chronic renal failure. Br Med J 1975 3.87
4 Modelling in economic evaluation: an unavoidable fact of life. Health Econ 1997 3.40
5 Variations in GP night visiting rates: medical organisation and consumer demand. Br Med J 1977 3.24
6 Final follow-up of the Multicentre Aneurysm Screening Study (MASS) randomized trial of abdominal aortic aneurysm screening. Br J Surg 2012 2.55
7 The episode-free day as a composite measure of effectiveness: an illustrative economic evaluation of formoterol versus salbutamol in asthma therapy. Pharmacoeconomics 1993 2.26
8 Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet 1998 1.94
9 Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study. BMJ 2007 1.81
10 Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet 1994 1.78
11 A relative cost-effectiveness analysis of different methods of screening for diabetic retinopathy. Diabet Med 1991 1.55
12 Radiology report times: impact of picture archiving and communication systems. AJR Am J Roentgenol 1998 1.55
13 The benefits of hospital-wide picture archiving and communication systems: a survey of clinical users of radiology services. Br J Radiol 1999 1.47
14 Screening for diabetic retinopathy: a relative cost-effectiveness analysis of alternative modalities and strategies. Health Econ 1992 1.46
15 Distribution of hospital provision: policy themes and resource variations. Br Med J 1975 1.42
16 Assessing the costs of healthcare technologies in clinical trials. Health Technol Assess 1999 1.39
17 Population characteristics and the distribution of general medical practitioners. Br Med J 1979 1.28
18 Measuring the effectiveness of heart transplant programmes: quality of life data and their relationship to survival analysis. J Chronic Dis 1987 1.27
19 How cost-effective is screening for abdominal aortic aneurysms? J Med Screen 2007 1.14
20 The time trade-off technique: how do the valuations of breast cancer patients compare to those of other groups? Qual Life Res 1994 1.14
21 Modelling the long-term cost-effectiveness of endovascular or open repair for abdominal aortic aneurysm. Br J Surg 2008 1.13
22 Resource allocation for chronic stable angina: a systematic review of effectiveness, costs and cost-effectiveness of alternative interventions. Health Technol Assess 1998 1.12
23 Systematic review and meta-analysis of the growth and rupture rates of small abdominal aortic aneurysms: implications for surveillance intervals and their cost-effectiveness. Health Technol Assess 2013 1.01
24 Identifying the impact of diabetes research. Diabet Med 2006 0.97
25 Health-related quality of life following liver transplantation. Qual Life Res 1998 0.92
26 A UK trial-based cost--utility analysis of transmyocardial laser revascularization compared to continued medical therapy for treatment of refractory angina pectoris. Eur J Cardiothorac Surg 2001 0.91
27 Examining the influence of picture archiving communication systems and other factors upon the length of stay for patients with total hip and total knee replacements. Int J Technol Assess Health Care 1999 0.91
28 The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial. Heart 2007 0.86
29 An economic evaluation of transdermal glyceryl trinitrate in the prevention of intravenous infusion failure. J Clin Epidemiol 1990 0.84
30 Economic forces and hospital technology. A perspective from Europe. Int J Technol Assess Health Care 1987 0.83
31 Anti-coagulant monitoring service delivery: a comparison of costs of hospital and community outreach clinics. Clin Lab Haematol 2000 0.82
32 Clinical and cost-effectiveness analysis of an open label, single-centre, randomised trial of spinal cord stimulation (SCS) versus percutaneous myocardial laser revascularisation (PMR) in patients with refractory angina pectoris: The SPiRiT trial. Trials 2008 0.81
33 Relationship between functional status and health-related quality-of-life after myocardial infarction. Med Care 1993 0.79
34 Cost-effectiveness of the National Health Service Abdominal Aortic Aneurysm Screening Programme in England. Br J Surg 2014 0.76
35 Cost minimisation study of transdermal glyceryl trinitrate in reducing failures of peripheral intravenous infusion. BMJ 1989 0.75
36 Cost effectiveness of the implantable cardioverter defibrillator: a preliminary analysis. Br Heart J 1992 0.75
37 Population screening for abdominal aortic aneurysm. J Public Health Med 1994 0.75
38 Cost-effectiveness as a guide to pricing a new pharmaceutical product. S Afr Med J 1994 0.75
39 Explaining variation in radiologists' reporting times. Br J Radiol 1995 0.75
40 Managing new technology: economics research and practical decisions. Health Serv Manage Res 1988 0.75
41 Assessing low volume, high cost, potentially life saving surgical interventions: how and when? Left ventricular assist devices (LVADs) as a case study. J Eval Clin Pract 1999 0.75
42 Letter: The cost of death. Lancet 1975 0.75
43 What is the cost of primary care and who pays the bill? Cost constraints and financial incentives. Ann N Y Acad Sci 1978 0.75
44 Economic evaluation of treatments for respiratory disease. Pharmacoeconomics 1992 0.75